Skip to main content
Clinical Trials/NL-OMON48139
NL-OMON48139
Completed
Not Applicable

Clinical validation of non-invasive tissue perfusion measurements in Vascular diseased patients with PeriFlux 6000 Enhanced Perfusion and Oxygen Saturation (EPOS) system * Pilot study - The VEPOS study

niversitair Medisch Centrum Groningen0 sites30 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Constricted bloodflow to the legs
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • 18 years and older and written informed consent with either;
  • \- Healthy volunteer, Rutherford classification 0
  • \- Non\- critical limb ischemia, Rutherford classification 2 and 3\.
  • \- Critical limb ischemia, Rutherford classification 4 to 6\.

Exclusion Criteria

  • \- Insufficient knowledge of the Dutch language, illiteracy or language barrier
  • \- Concurrent uncontrolled medical conditions
  • \- Lower leg fractures within the past 12 months.
  • \- (Partial) amputation of one of the feet and/or legs.
  • \- Pregnant or breast feeding.
  • \- Severe peripheral oedema.
  • \- Severe cardiac\-pulmonary failure.
  • \- Active cellulitis\-erysipelas of the legs or other dermatological diseases.

Outcomes

Primary Outcomes

Not specified

Similar Trials